These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Syntheses and in vitro evaluation of 4-(2-aminoethyl)-2(3H)-indolones and related compounds as peripheral prejunctional dopamine receptor agonists. DeMarinis RM; Gallagher G; Hall RF; Franz RG; Webster C; Huffman WF; Schwartz MS; Kaiser C; Ross ST; Wilson JW J Med Chem; 1986 Jun; 29(6):939-47. PubMed ID: 3712384 [TBL] [Abstract][Full Text] [Related]
4. Prejunctional inhibitory effect of a dopamine D-2 agonist, N-0437, on vascular adrenergic responses. Friedman DJ; Budai D; Krause DN; Duckles SP J Pharmacol Exp Ther; 1989 Sep; 250(3):853-9. PubMed ID: 2674420 [TBL] [Abstract][Full Text] [Related]
5. Neuroinhibitory effects of SK&F 85174, a novel dopamine receptor agonist. Blumberg AL; Wilson JW; Hieble JP J Cardiovasc Pharmacol; 1985; 7(4):723-32. PubMed ID: 2410714 [TBL] [Abstract][Full Text] [Related]
6. Dopamine receptor agonist activity of some 5-(2-aminoethyl)carbostyril derivatives. Kaiser C; Dandridge PA; Garvey E; Flaim KE; Zeid RL; Hieble JP J Med Chem; 1985 Dec; 28(12):1803-10. PubMed ID: 4068005 [TBL] [Abstract][Full Text] [Related]
7. Prejunctional dopamine receptors modulate twitch responses to parasympathetic nerve stimulation in the rabbit isolated rectococcygeus muscle. Drew GM; Hilditch A Br J Pharmacol; 1984 Dec; 83(4):871-81. PubMed ID: 6151412 [TBL] [Abstract][Full Text] [Related]
8. Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum. Onali P; Olianas MC; Gessa GL Mol Pharmacol; 1985 Aug; 28(2):138-45. PubMed ID: 2410769 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of N,N-di-n-propyltetrahydrobenz[f]indol-7-amine and related congeners as dopaminergic agonists. Nichols DE; Cassady JM; Persons PE; Yeung MC; Clemens JA; Smalstig EB J Med Chem; 1989 Sep; 32(9):2128-34. PubMed ID: 2570151 [TBL] [Abstract][Full Text] [Related]
10. Pharmacological differences between the D-2 autoreceptor and the D-1 dopamine receptor in rabbit retina. Dubocovich ML; Weiner N J Pharmacol Exp Ther; 1985 Jun; 233(3):747-54. PubMed ID: 4009487 [TBL] [Abstract][Full Text] [Related]
11. 6-Hydroxy-4-[2-(di-n-propylamino)ethyl]indole: synthesis and dopaminergic actions. Cannon JG; Lee T; Ilhan M; Koons J; Long JP J Med Chem; 1984 Mar; 27(3):386-9. PubMed ID: 6699883 [TBL] [Abstract][Full Text] [Related]
12. Pharmacological and biochemical characterization of the D-1 dopamine receptor mediating acetylcholine release in rabbit retina. Hensler JG; Cotterell DJ; Dubocovich ML J Pharmacol Exp Ther; 1987 Dec; 243(3):857-67. PubMed ID: 2961878 [TBL] [Abstract][Full Text] [Related]
13. Interactions of salsolinol and its mono-O-methylated analogs with adrenergic and dopaminergic receptors in the rabbit ear artery. Nelson SH; Steinsland OS J Pharmacol Exp Ther; 1983 Jan; 224(1):193-8. PubMed ID: 6294277 [TBL] [Abstract][Full Text] [Related]
14. Activation of DA1 receptors by dopamine or fenoldopam increases cyclic AMP levels in the renal artery but not in the superior cervical ganglion of the rat. Alkadhi KA; Sabouni MH; Ansari AF; Lokhandwala MF J Pharmacol Exp Ther; 1986 Aug; 238(2):547-53. PubMed ID: 2874213 [TBL] [Abstract][Full Text] [Related]
15. RDS-127 (2-di-n-propylamino-4,7-dimethoxyindane): central effects of a new dopamine receptor agonist. Arnerić SP; Long JP; Williams M; Goodale DB; Mott J; Lakoski JM; Gebhart GF J Pharmacol Exp Ther; 1983 Jan; 224(1):161-70. PubMed ID: 6401334 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of non-catechol D-1 and D-2 dopamine receptor agonists: benzimidazol-2-one, benzoxazol-2-one, and the highly potent benzothiazol-2-one 7-ethylamines. Weinstock J; Gaitanopoulos DE; Stringer OD; Franz RG; Hieble JP; Kinter LB; Mann WA; Flaim KE; Gessner G J Med Chem; 1987 Jul; 30(7):1166-76. PubMed ID: 2955118 [TBL] [Abstract][Full Text] [Related]
17. trans-10,11-dihydroxy-5,6,6a,7,8,12b-hexahydrobenzo[a]phenanthridine: a highly potent selective dopamine D1 full agonist. Brewster WK; Nichols DE; Riggs RM; Mottola DM; Lovenberg TW; Lewis MH; Mailman RB J Med Chem; 1990 Jun; 33(6):1756-64. PubMed ID: 1971308 [TBL] [Abstract][Full Text] [Related]
18. D2-dopamine receptor-mediated inhibition of intracellular Ca2+ mobilization and release of acetylcholine from guinea-pig neostriatal slices. Fujiwara H; Kato N; Shuntoh H; Tanaka C Br J Pharmacol; 1987 Jun; 91(2):287-97. PubMed ID: 2886167 [TBL] [Abstract][Full Text] [Related]
19. Aporphines, 36. Dopamine receptor interactions of trihydroxyaporphines. Synthesis, radioreceptor binding, and striatal adenylate cyclase stimulation of 2,10,11-trihydroxyaporphines in comparison with other hydroxylated aporphines. Neumeyer JL; Arana GW; Law SJ; Lamont JS; Kula NS; Baldessarini RJ J Med Chem; 1981 Dec; 24(12):1440-5. PubMed ID: 7310821 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and dopamine receptor affinities of 6-amino-5,6,7,8-tetrahydroquinoline derivatives. Claudi F; Cingolani GM; Giorgioni G; Cattabeni F; Cimino M; Di Luca M Drug Des Deliv; 1989 Jun; 4(4):279-87. PubMed ID: 2570592 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]